Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TD-1211 in Healthy Volunteers and Opioid-Induced Constipation
NCT01040637Phase 2Completed
- Sponsor
- Glycyx Therapeutics
- Start
- Jan 2010
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of axelopran in opioid-induced constipation (OIC), sponsored by Glycyx Therapeutics. Started Jan 2010; status: completed.
02
Drugs
axelopran
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT01040637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01040637.